Prospective study assesses biomarkers predicting mortality in trauma patients, suggesting better risk stratification methods.
Interleukin-6 (IL-6), serum lactate, base deficit (BD), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were assessed for their prognostic value in predicting mortality and clinical outcomes in trauma patients. A prospective, observational study was conducted at Poursina Educational Trauma Center between May and August 2023, enrolling 114 patients with moderate to severe injuries (Injury Severity Score > 12). Admission data, including demographic, clinical, and laboratory parameters, were collected, with in-hospital mortality and length of stay as primary outcomes. The overall mortality rate was 11.4%, with non-survivors presenting with higher Injury Severity Scores, lower Glasgow Coma Scale scores, and elevated IL-6 and lactate levels. ROC analysis identified IL-6 as the most accurate predictor of mortality (AUC = 0.948), followed by BD and lactate, while CRP and ESR had limited predictive value. IL-6 demonstrated superior prognostic accuracy for early mortality, although BD and lactate remain crucial in resource-limited settings where IL-6 testing may not be feasible. These findings highlight the potential of integrating inflammatory and perfusion biomarkers to improve early risk stratification in trauma care.
No takes yet. Share an insight, caveat, or question.
Eftekhari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: